top of page
Hope4ATRT_Logo_small.png

TAZNI: A Phase I/II Combination Trial of Tazemetostat with Nivolumab and Ipilimumab for Children with INI1-Negative or SMARCA4-Deficient Tumors

Summary

Trial Information

Approach

Additional Information

Eligibility

Contact Information

bottom of page